354 related articles for article (PubMed ID: 20616044)
1. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
Wüstehube J; Bartol A; Liebler SS; Brütsch R; Zhu Y; Felbor U; Sure U; Augustin HG; Fischer A
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12640-5. PubMed ID: 20616044
[TBL] [Abstract][Full Text] [Related]
2. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
[TBL] [Abstract][Full Text] [Related]
3. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
4. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
[TBL] [Abstract][Full Text] [Related]
6. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.
Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A
Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711
[TBL] [Abstract][Full Text] [Related]
8. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
[TBL] [Abstract][Full Text] [Related]
9. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
10. Ccm1 regulates microvascular morphogenesis during angiogenesis.
Liu H; Rigamonti D; Badr A; Zhang J
J Vasc Res; 2011; 48(2):130-40. PubMed ID: 20926893
[TBL] [Abstract][Full Text] [Related]
11. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
12. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
Hasan SS; Fischer A
Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
[TBL] [Abstract][Full Text] [Related]
13. EndMT contributes to the onset and progression of cerebral cavernous malformations.
Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
[TBL] [Abstract][Full Text] [Related]
14. Concepts and hypothesis: integrin cytoplasmic domain-associated protein-1 (ICAP-1) as a potential player in cerebral cavernous malformation.
Zheng Y; Qiu J; Hu J; Wang G
J Neurol; 2013 Jan; 260(1):10-9. PubMed ID: 22711159
[TBL] [Abstract][Full Text] [Related]
15. Postzygotic mosaicism in cerebral cavernous malformation.
Rath M; Pagenstecher A; Hoischen A; Felbor U
J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
[TBL] [Abstract][Full Text] [Related]
17. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
18. Lack of CCM1 induces hypersprouting and impairs response to flow.
Mleynek TM; Chan AC; Redd M; Gibson CC; Davis CT; Shi DS; Chen T; Carter KL; Ling J; Blanco R; Gerhardt H; Whitehead K; Li DY
Hum Mol Genet; 2014 Dec; 23(23):6223-34. PubMed ID: 24990152
[TBL] [Abstract][Full Text] [Related]
19. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
20. Study of CCM Microvascular Endothelial Phenotype by an In Vitro Tubule Differentiation Model.
Delle Monache S; Retta SF
Methods Mol Biol; 2020; 2152():371-375. PubMed ID: 32524565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
